Radiance RDX System Expanded Clinical Trials Targeted For Year-End
This article was originally published in The Gray Sheet
Executive Summary
Radiance Medical hopes to receive final FDA approval for its RDX balloon catheter radiation delivery system in the second half of 2001.
You may also be interested in...
SVG Potential Indication Could Bring A Glow To Brachytherapy Contender
The solid beta radiation source balloon technology employed by Radiance Medical Systems' RDX radiation delivery catheter will present an advantage over competing intravascular brachytherapy systems in treating restenotic saphenous vein grafts (SVG), according to the Irvine, California firm.
SVG Potential Indication Could Bring A Glow To Brachytherapy Contender
The solid beta radiation source balloon technology employed by Radiance Medical Systems' RDX radiation delivery catheter will present an advantage over competing intravascular brachytherapy systems in treating restenotic saphenous vein grafts (SVG), according to the Irvine, California firm.
Medtronic Acquires XRT, Gains Brachytherapy Restenosis Technology
Medtronic plans to submit an investigational device exemption application in the third quarter for the soft x-ray brachytherapy technology it has obtained as a result of the recent acquisition of privately held XRT Corp.